Skip to main content

Advertisement

Table 1 Baseline characteristics

From: Prognostic value of new left atrial volume index severity partition cutoffs after cardiac rehabilitation program in patients undergoing cardiac surgery

Parameters Normal LA (LAVi ≤ 34 ml/m2) LA Enlargement (LAVi > 34 ml/m2)
  N = 306 N = 257
Age (years) 68 (10) 71 (9)**
Male sex 245 (61) 154 (39)**
BMI (kg/m2) 26.9 (4) 26.7 (4)
BSA (m2) 1.9 (0.2) 1.8 (0.2)**
CV risk Factors
 Familiar history (CVD) 159 (56) 120 (44)
 AHT 159 (52) 146 (48)
 DM 83 (55) 66 (45)
 Dyslipidaemia 165 (57) 120 (43)
Types of cardiac surgery
 CABG 197 (75) 95 (25)**
 Heart-valve surgery 73 (25) 118 (75)**
 CABG + Valve surgery 37 (46) 43 (54)
Clinical indications
 ACS 116 (63) 68 (37)*
 Stable Angina 66 (67) 32 (33)*
 MV Stenosis 2 (22) 7 (78)
 MV regurgitation 44 (44) 56 (56)*
 AV Stenosis 23 (32) 20 (68)**
 AV regurgitation 19 (46) 22 (54)
 Other indication 36 (62) 22 (38)
Echocardiographic parameters
 LAV (ml) 49 (11) 85 (22)**
 LAd (mm) 38 (5) 54 (6)**
 LVEF (%) 52 (9) 49 (10)*
 LV EDV (ml) 105 (41) 108 (42)
 IVS (mm) 12 (2) 13 (2)**
 E/A Ratio 1 (0.4) 1 (0.6)
Medications
 β-Blocker 201 (52) 185 (48)
 Amiodarone 79 (51) 77 (49)
 OAT 72 (38) 117 (62)**
 ACEi 216 (57) 170 (43)**
 Statins 218 (56) 168 (44)**
  1. Values are expressed as mean and standard deviation or as number and percentage
  2. LA left atrium; LAVi left atrial volume index; BMI body mass index; CVD cardiovascular disease; AHT arterial hypertension; DM diabetes mellitus; CABG coronary artery bypass graft; ACS acute coronary syndrome; MV mitral valve; AV aortic valve; Lad left atrium antero-posteior diameter; LVEF left ventricular ejection fraction; IVSs interventricular septum; LV EDV left ventricular end-diastolic volume; OAT oral anticoagulant therapy
  3. *and **indicate differences at significance levels p <0.05 and p <0.01 respectively